Dr Cole Seifert, PhDResearch & Technology Specialist at Croda Inc.Speaker
Profile
Dr. Cole Seifert obtained his Bachelor’s and PhD in Chemistry from Texas Tech University. During his PhD research, Dr. Seifert invented Group-Assisted Purification (GAP) Peptide Synthesis Technology and secured investment to commercialize the technology via the startup company, GAP Peptides, LLC. From 2017 – 2022 he served as GAP Peptides’ President and Chief Scientific Officer, and led the development of scalable, sustainable methods for peptide and biopolymer synthesis. Following acquisition of GAP Technology by Croda, Inc. in 2022, Dr. Seifert now leads peptide development activities at Croda.